Results (3746)
Benefits of Ocaliva no longer considered to outweigh its risks

MSSG recommendations for all stakeholders and upcoming multistakeholder workshop
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.

Revised rules for Clinical Trials Information System (CTIS) become applicable
Review will look into risk of agranulocytosis, a sudden drop in white blood cells that can lead to serious infections, and measures to minimise it.

Start of review of painkiller metamizole and risk of secondary cancers with CAR T-cell medicines.

Board adopts Executive Director’s annual activity report for 2023 and hears updates on implementation of new fee regulation.

Pilots are part of ACT EU collaboration to foster high-quality clinical research in the EU.
EMA has issued recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2024.

14 new medicines recommended for approval; another seven medicines are recommended for extension of their therapeutic indications